CANDAPI LTD
General Data
Reg Number
516586880
Sector
Medical Devices
Established
2022
No. of Employees
5
Stage
R&D
Additional Funding
1
Description
A dry powder inhaler with an efficiency that is not recognized in the market of 90% for the treatment of lung diseases, and for the use of new biological drugs and cannabis for systemic treatments
Technology
CanDapi develops an accurate dry powder inhaler, customized for the users' generic or novel inhaled medication. The company's inhaler is simple to use, suits every patient – from babies, through lung disease patients to the elderly – without the need of complicated user instructions.
Targeted Customers
Hospitals.
Management personnel
Amnon Kritzman-Kadron - CEO & Founder
Winning details
Route name
Winning year
Periphery Entrepreneurship Incubators
Periphery Entrepreneurship Incubators
2023